Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong · Delayed Price · Currency is HKD 3.260
0.00 (0.00%)
Aug 21, 2026, 4:08 PM HKT
HKG:0241 Ratios and Metrics
Market cap in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 52,698 | 75,329 | 75,749 | 51,139 | 76,743 | 68,618 | |
Market Cap Growth | -38.76% | -0.55% | 48.12% | -33.36% | 11.84% | -76.86% |
Enterprise Value | 41,212 | 65,153 | 67,229 | 38,213 | 64,393 | 55,039 |
Last Close Price | 3.26 | 4.37 | 4.42 | 2.98 | 5.33 | 4.76 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 24.00 | 34.23 | 49.32 | 53.41 | 125.37 | - |
Forward PE | 21.72 | 24.36 | 34.32 | 38.54 | 177.51 | 298.27 |
PS Ratio | 1.35 | 1.94 | 2.31 | 1.75 | 2.51 | 2.70 |
PB Ratio | 2.60 | 3.71 | 4.33 | 3.25 | 4.43 | 3.95 |
P/TBV Ratio | 2.76 | 3.95 | 4.64 | 3.51 | 4.78 | 4.29 |
P/FCF Ratio | 37.76 | 53.98 | 51.34 | 44.64 | 268.54 | 135.67 |
P/OCF Ratio | 37.49 | 53.59 | 50.64 | 43.69 | 262.64 | 130.89 |
PEG Ratio | 0.97 | 0.64 | 0.84 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.06 | 1.67 | 2.05 | 1.31 | 2.11 | 2.17 |
EV/EBITDA Ratio | 19.24 | 30.83 | 42.20 | 53.52 | - | - |
EV/EBIT Ratio | 19.80 | 31.35 | 43.14 | 55.54 | - | - |
EV/FCF Ratio | 29.53 | 46.69 | 45.57 | 33.35 | 225.32 | 108.82 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
Debt / EBITDA Ratio | 0.03 | 0.03 | 0.02 | 0.12 | 6.37 | - |
Debt / FCF Ratio | 0.05 | 0.05 | 0.03 | 0.08 | 0.31 | 0.33 |
Net Debt / Equity Ratio | -0.57 | -0.57 | -0.49 | -0.65 | -0.72 | -0.74 |
Net Debt / EBITDA Ratio | -5.43 | -5.43 | -5.43 | -14.38 | 442.84 | 9.67 |
Net Debt / FCF Ratio | -8.23 | -8.23 | -5.86 | -8.96 | -43.34 | -25.43 |
Asset Turnover | 1.55 | 1.55 | 1.50 | 1.34 | 1.34 | 1.11 |
Inventory Turnover | 15.96 | 15.96 | 16.46 | 12.07 | 11.53 | 10.91 |
Quick Ratio | 2.48 | 2.48 | 2.15 | 2.28 | 2.24 | 2.41 |
Current Ratio | 3.03 | 3.03 | 2.59 | 2.69 | 2.74 | 2.81 |
Return on Equity (ROE) | 11.33% | 11.33% | 9.29% | 5.95% | 3.67% | -1.88% |
Return on Assets (ROA) | 5.16% | 5.16% | 4.44% | 1.96% | -0.16% | -3.72% |
Return on Invested Capital (ROIC) | 20.09% | 19.46% | 20.07% | 12.76% | -1.26% | -34.64% |
Return on Capital Employed (ROCE) | 10.20% | 10.20% | 8.80% | 4.30% | -0.30% | -7.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.18% | 2.92% | 2.03% | 1.87% | 0.80% | -0.48% |
FCF Yield | 2.65% | 1.85% | 1.95% | 2.24% | 0.37% | 0.74% |
Dividend Yield | 2.13% | 1.55% | - | - | - | - |
Buyback Yield / Dilution | -0.39% | -0.39% | -14.51% | -4.06% | -0.44% | -1.17% |
Total Shareholder Return | 1.74% | 1.16% | -14.51% | -4.06% | -0.44% | -1.17% |